SARS‐CoV‐2 vaccination in pediatric patients with immune thrombocytopenia-Reference-Cited by-同舟云学术

SARS‐CoV‐2 vaccination in pediatric patients with immune thrombocytopenia

Published:2022-05-13 Issue:7 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Hillier Kirsty¹^ORCID,Rothman Jennifer A.²^ORCID,Klaassen Robert J.³^ORCID,Neunert Cindy⁴^ORCID,Rose Melissa J.⁵,Grace Rachael F.⁶,Lambert Michele P.⁷⁸^ORCID

Affiliation:

1. Department of Pediatrics Division of Pediatric Hematology‐Oncology Hassenfeld Children's Hospital at NYU Langone Health NYU Grossman School of Medicine New York New York USA

2. Department of Pediatrics Duke University Medical Center Durham North Carolina USA

3. Division of Hematology/Oncology, Department of Pediatrics Children's Hospital of Eastern Ontario Research Institute Ottawa Ontario Canada

4. Division of Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics Columbia University Irving Medical Center New York New York USA

5. Nationwide Children's and The Ohio State University Wexner Medical Center Columbus Ohio USA

6. Pediatric Hematology/Oncology Dana‐Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School Boston Massachusetts USA

7. Division of Hematology The Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

8. Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29760

Reference29 articles.

1. FDA.FDA Authorizes Pfizer‐BioNTech COVID‐19 Vaccine for Emergency Use in Children 5 through 11 Years of Age.FDA;2021.https://www.fda.gov/news‐events/press‐announcements/fda‐authorizes‐pfizer‐biontech‐covid‐19‐vaccine‐emergency‐use‐children‐5‐through‐11‐years‐age. Accessed February 7 2022.

2. GradyD MazzeiP.Doctor's death after COVID vaccine is being investigated.The New York Times. January 12 2021.https://www.ncbi.nlm.nih.gov/search/research‐news/12431/. Accessed February 7 2022.

3. Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination

4. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

5. SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia following SARS‐CoV‐2 vaccination in a female: Report of one case;Pediatric Blood & Cancer;2023-02

2. Effects of COVID‐19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia;Pediatric Blood & Cancer;2022-11